ArticleBMC cancer2024

SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.

Johanna S Enke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.